Urinary Bladder Neoplasms
Oncology·MeSH: Urinary Bladder Neoplasms
Prevalence
61.0 / 100K
Incidence
18.0 / 100K/yr
12 drugs in development·7 companies·13 clinical trials
Drug Pipeline by Phase
Phase 3(7)
Phase 2(3)
Phase 1(2)
Compare drugs
Frequently asked questions
How many drugs are in development for Urinary Bladder Neoplasms?
BioSniper tracks 12 drugs in development for Urinary Bladder Neoplasms across 7 companies.
How many clinical trials target Urinary Bladder Neoplasms?
There are 13 clinical trials targeting Urinary Bladder Neoplasms tracked by BioSniper.
What is the prevalence of Urinary Bladder Neoplasms?
The estimated prevalence of Urinary Bladder Neoplasms is approximately 61.0 per 100,000 population.
Deep-dive into Urinary Bladder Neoplasms
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis